OpenURL Connection Search

Select item for more details and to access through your institution.

Fluconazole and fungal ocular infection.
Published in:
1990
By:
- CRUCIANI, M.;
- PERRI, G. DI;
- CONCIA, E.;
- BASSETTI, D.;
- BONORA, A.;
- MECCA, E.;
- PANOZZO, G.;
- TOMAZZOLI, L.;
- Di Perri, G
Publication type:
commentary
Antiretroviral concentrations in the presence and absence of valproic acid.
Published in:
2020
By:
- Calcagno, A;
- Cusato, J;
- Ferrara, M;
- Nicolò, A De;
- Lazzaro, A;
- Manca, A;
- D'Avolio, A;
- Perri, G Di;
- Bonora, S;
- De Nicolò, A;
- Di Perri, G
Publication type:
journal article
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors.
Published in:
2013
By:
- Calcagno A;
- Tettoni MC;
- Simiele M;
- Trentini L;
- Montrucchio C;
- D'Avolio A;
- Di Perri G;
- Bonora S
Publication type:
Journal Article
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors.
Published in:
2013
By:
- Calcagno, A.;
- Tettoni, M. C.;
- Simiele, M.;
- Trentini, L.;
- Montrucchio, C.;
- D'Avolio, A.;
- Di Perri, G.;
- Bonora, S.
Publication type:
Letter
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS.
Published in:
2012
By:
- Baietto L;
- D'Avolio A;
- Marra C;
- Simiele M;
- Cusato J;
- Pace S;
- Ariaudo A;
- De Rosa FG;
- Di Perri G
Publication type:
Journal Article
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination.
Published in:
2011
By:
- Calcagno A;
- Nozza S;
- Bonora S;
- Castagna A;
- Gonzalez de Requena D;
- D'Avolio A;
- Lazzarin A;
- Di Perri G
Publication type:
Journal Article
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 224, doi. 10.1093/jac/dkq385
By:
- Calcagno, A.;
- Baietto, L.;
- De Rosa, F. G.;
- Tettoni, M. C.;
- Libanore, V.;
- Bertucci, R.;
- D'Avolio, A.;
- Di Perri, G.
Publication type:
Article
Is peritoneal fluid a sanctuary site for HIV?
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 9, p. 2052, doi. 10.1093/jac/dkq235
By:
- Calcagno, A.;
- Rostagno, R.;
- Audagnotto, S.;
- D'Avolio, A.;
- Bonora, S.;
- Ghisetti, V.;
- Di Perri, G.
Publication type:
Article
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 4, p. 919, doi. 10.1093/jac/dkn013
By:
- D. Aguilar Marucco;
- D. Gonzalez de Requena;
- S. Bonora;
- C. Tettoni;
- M. Bonasso;
- T. De Blasi;
- A. DAvolio;
- M. Sciandra;
- M. Siccardi;
- L. Baietto;
- L. Trentini;
- A. Sinicco;
- G. Cariti;
- G. Di Perri
Publication type:
Article
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 59, n. 3, p. 565, doi. 10.1093/jac/dkl497
By:
- D. Aguilar Marucco;
- L. Veronese;
- D. Gonzalez de Requena;
- S. Bonora;
- A. Calcagno;
- I. Cavecchia;
- A. Sinicco;
- F. G. De Rosa;
- G. Cariti;
- G. Di Perri
Publication type:
Article
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 6, p. 1055, doi. 10.1093/jac/dkl113
By:
- G. Carosi;
- C. Torti;
- M. Andreoni;
- G. Angarano;
- A. Antinori;
- S. Bonora;
- M. Borderi;
- A. Castagna;
- F. Castelli;
- R. Cauda;
- F. Chiodo;
- A. D'arminio-Monforte;
- A. De Luca;
- G. Di Perri;
- F. Dianzani;
- G. Filice;
- M. Galli;
- A. Lazzarin;
- F. Maggiolo;
- R. Maserati
Publication type:
Article
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid.
Published in:
2000
By:
- Allegranzi, B.;
- Cazzadori, A.;
- Di Perri, G.;
- Bonora, S.;
- Berti, M.;
- Franchino, L.;
- Biglino, A.;
- Cipriani, A.;
- Concia, E.
Publication type:
journal article
Rapid absorption and clinical effectiveness of intragastric mefloquine in the treatment of cerebral malaria in African children.
Published in:
1999
By:
- Di Perri, Giovanni;
- Olliaro, Piero;
- Ward, Stephen;
- Allegranzi, Benedetta;
- Bonora, Stefano;
- Concia, Ercole;
- Di Perri, G;
- Olliaro, P;
- Ward, S;
- Allegranzi, B;
- Bonora, S;
- Concia, E
Publication type:
journal article
Pharmacokinetics, safety and anti-human immunodeficiency virus (HIV) activity of hydroxyurea in combination with didanosine.
Published in:
1998
By:
- Luzzati, R;
- Di Perri, G;
- Fendt, D;
- Ramarli, D;
- Broccali, G;
- Concia, E
Publication type:
clinical trial
Letter. Pharmacokinetics, safety and anti-human immunodeficiecy virus (HIV) activity of hydroxyurea in combination with didanosine.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 565, doi. 10.1093/jac/42.4.565
By:
- Luzzati, R;
- Di Perri, G;
- Fendt, D;
- Ramarli, D;
- Broccali, G;
- Concia, E
Publication type:
Article
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders.
Published in:
Journal of NeuroVirology, 2022, v. 28, n. 2, p. 226, doi. 10.1007/s13365-021-01047-y
By:
- Barco, A.;
- Orlando, S.;
- Stroffolini, G.;
- Pirriatore, V.;
- Lazzaro, A.;
- Vai, D.;
- Guastamacchia, G.;
- Noce, G.;
- Atzori, C.;
- Trunfio, M.;
- Bonora, S.;
- Di Perri, G.;
- Calcagno, A.
Publication type:
Article
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.
Published in:
Journal of NeuroVirology, 2016, v. 22, n. 1, p. 88, doi. 10.1007/s13365-015-0371-x
By:
- Calcagno, A.;
- Atzori, C.;
- Romito, A.;
- Vai, D.;
- Audagnotto, S.;
- Stella, M.;
- Montrucchio, C.;
- Imperiale, D.;
- Di Perri, G.;
- Bonora, S.
Publication type:
Article
Prevalence and predictors of blood-brain barrier damage in the HAART era.
Published in:
Journal of NeuroVirology, 2014, v. 20, n. 5, p. 521, doi. 10.1007/s13365-014-0266-2
By:
- Calcagno, A.;
- Alberione, M. C.;
- Romito, A.;
- Imperiale, D.;
- Ghisetti, V.;
- Audagnotto, S.;
- Lipani, F.;
- Raviolo, S.;
- Di Perri, G.;
- Bonora, S.
Publication type:
Article
Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort.
Published in:
Journal of the International AIDS Society, 2019, v. 22, n. 1, p. 1, doi. 10.1002/jia2.25227
By:
- Mondi, Annalisa;
- Cozzi‐Lepri, Alessandro;
- Tavelli, Alessandro;
- Rusconi, Stefano;
- Vichi, Francesca;
- Ceccherini‐Silberstein, Francesca;
- Calcagno, Andrea;
- De Luca, Andrea;
- Maggiolo, Franco;
- Marchetti, Giulia;
- Antinori, Andrea;
- d'Arminio Monforte, Antonella;
- Andreoni, M;
- Castagna, A;
- Castelli, F;
- Cauda, R;
- Di Perri, G;
- Galli, M;
- Iardino, R;
- Ippolito, G
Publication type:
Article
Impact of antiretroviral dosing frequency and daily pill burden on virological success rates in patients of the ICoNA cohort starting their first ART.
Published in:
Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18233
By:
- Ammassari, A;
- Lorenzini, P;
- Mussini, C;
- Cozzi-Lepri, A;
- Baldelli, F;
- Gori, A;
- Andreoni, M;
- Tozzi, V;
- Di Perri, G;
- Lazzarin, A;
- Quirino, T;
- Cassola, G;
- d'Arminio Monforte, A;
- Antinori, A
Publication type:
Article
Durability of lopinavir/r monotherapy in people with viral load ≤50 copies/Ml.
Published in:
Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18378
By:
- d'Arminio Monforte, A;
- Cozzi-Lepri, A;
- Andreoni, M;
- di Perri, G;
- Galli, M;
- Poli, A;
- Costantini, A;
- Maggiolo, F;
- Viscoli, C;
- Sighinolfi, L;
- Rizzardini, G;
- Bonfanti, P;
- Gianotti, N;
- Perno, C;
- Antinori, A
Publication type:
Article
Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P48, doi. 10.1186/1758-2652-13-S4-P48
By:
- Bonora, S;
- Calcagno, A;
- Viganò, O;
- Bigliano, P;
- Rusconi, S;
- Trentini, L;
- Tettoni, MC;
- Orofino, G;
- Salassa, B;
- Bramato, C;
- D'Avolio, A;
- Siccardi, M;
- Colella, E;
- Galli, M;
- Di Perri, G
Publication type:
Article
SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P178, doi. 10.1186/1758-2652-13-S4-P178
By:
- Siccardi, M;
- D'Avolio, A;
- Baietto, L;
- Simiele, M;
- Bonora, S;
- Back, DJ;
- Di Perri, G;
- Owen, A
Publication type:
Article
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P179, doi. 10.1186/1758-2652-13-S4-P179
By:
- Calcagno, A;
- Milia, MG;
- D'Avolio, A;
- Ndayishimiyae, P;
- Dusabimana, P;
- Bonora, S;
- Cusato, J;
- Simiele, M;
- Rostagno, R;
- Siccardi, M;
- Audagnotto, S;
- Ghisetti, V;
- Di Perri, G
Publication type:
Article
Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P84, doi. 10.1186/1758-2652-13-S4-P84
By:
- Uglietti, A;
- Gervasoni, C;
- Gabrielli, E;
- Di Giambenedetto, S;
- Cauda, R;
- Esposito, R;
- Grima, P;
- Di Perri, G;
- Maserati, R;
- Galli, M
Publication type:
Article
Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART.
Published in:
2010
By:
- Uglietti, A.;
- Gervasoni, C.;
- Gabrielli, E.;
- Di Giambenedetto, S.;
- Cauda, R.;
- Esposito, R.;
- Grima, P.;
- Di Perri, G.;
- Maserati, R.;
- Galli, M.
Publication type:
Abstract
Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting.
Published in:
2010
By:
- Bonora, S.;
- Calcagno, A.;
- Viganò, O.;
- Bigliano, P.;
- Rusconi, S.;
- Trentini, L.;
- Tettoni, M. C.;
- Orofino, G.;
- Salassa, B.;
- Bramato, C.;
- D'Avolio, A.;
- Siccardi, M.;
- Colella, E.;
- Galli, M.;
- Di Perri, G.
Publication type:
Abstract
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load.
Published in:
2010
By:
- Calcagno, A.;
- Milia, M. G.;
- D'Avolio, A.;
- Ndayishimiyae, P.;
- Dusabimana, P.;
- Bonora, S.;
- Cusato, J.;
- Simiele, M.;
- Rostagno, R.;
- Siccardi, M.;
- Audagnotto, S.;
- Ghisetti, V.;
- Di Perri, G.
Publication type:
Abstract
SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients.
Published in:
2010
By:
- Siccardi, M.;
- D'Avolio, A.;
- Baietto, L.;
- Simiele, M.;
- Bonora, S.;
- Back, D. J.;
- Di Perri, G.;
- Owen, A.
Publication type:
Abstract
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19.
Published in:
BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08297-7
By:
- Cosmi, B.;
- Giannella, M.;
- Fornaro, G.;
- Cristini, F.;
- Patacca, A.;
- Castagna, A.;
- Mazzaferri, F.;
- Testa, S.;
- Pan, A.;
- Lupi, M.;
- Brambilla, P.;
- Montineri, A.;
- Frattima, S.;
- Bignami, E. G.;
- Salvetti, M.;
- De Stefano, G.;
- Grandone, E.;
- Di Perri, G.;
- Rozzini, R.;
- Stella, A.
Publication type:
Article
Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus.
Published in:
European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 20, p. 7024
By:
- DI MARCO, V.;
- ALBERTI, A.;
- ANGARANO, G.;
- COLOMBO, M.;
- DI PERRI, G.;
- GAETA, G. B.;
- IPPOLITO, G.;
- MANGIA, A.;
- PASQUALETTI, P.;
- CRAXÌ, A.
Publication type:
Article
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman.
Published in:
2023
By:
- Di Girolamo, L.;
- Ferrara, M.;
- Trevisan, G.;
- Longo, B. M.;
- Allice, T.;
- Burdino, E.;
- Alladio, F.;
- Fantino, S.;
- Di Perri, G.;
- Calcagno, A.;
- Bonora, S.
Publication type:
Case Study
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.
Published in:
Infection, 2012, v. 40, n. 1, p. 69, doi. 10.1007/s15010-011-0223-4
By:
- Bonora, S.;
- Calcagno, A.;
- Cometto, C.;
- Fontana, S.;
- Aguilar, D.;
- D'Avolio, A.;
- Gonzalez de Requena, D.;
- Maiello, A.;
- Dal Conte, I.;
- Lucchini, A.;
- Di Perri, G.
Publication type:
Article
Cryoglobulinemia-Related Vasculitis During Effective Anti-HCV Treatment with PEG-Interferon alfa-2b.
Published in:
Infection, 2008, v. 36, n. 3, p. 285, doi. 10.1007/s15010-007-6299-1
By:
- de Blasi, T.;
- Aguilar Marucco, D.;
- Cariti, G.;
- Maiello, A.;
- Rosa, F. G.;
- di Perri, G.
Publication type:
Article
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006).
Published in:
Infection, 2007, v. 35, n. 3, p. 134, doi. 10.1007/s15010-007-6295-5
By:
- Carosi, G.;
- Quiros-Roldan, E.;
- Torti, C.;
- Antinori, A.;
- Bevilacqua, M.;
- Bonadonna, R. C.;
- Bonfanti, P.;
- Castagna, A.;
- Cauda, R.;
- d'Arminio-Monforte, A.;
- di Gregorio, P.;
- di Perri, G.;
- Esposito, R.;
- Fatuzzo, F.;
- Gervasoni, C.;
- Giannattasio, C.;
- Guaraldi, G.;
- Lazzarin, A.;
- Lo Caputo, S.;
- Maggi, P.
Publication type:
Article
Infective Endocarditis in Intravenous Drug Users from Italy: the Increasing Importance in HIV-infected Patients.
Published in:
Infection, 2007, v. 35, n. 3, p. 154, doi. 10.1007/s15010-007-5125-0
By:
- de Rosa, F. G.;
- Cicalini, S.;
- Canta, F.;
- Audagnotto, S.;
- Cecchi, E.;
- di Perri, G.
Publication type:
Article
Seborrhoeic dermatitis: an early manifestation in AIDS.
Published in:
Clinical & Experimental Dermatology, 1987, v. 12, n. 1, p. 72, doi. 10.1111/j.1365-2230.1987.tb01865.x
By:
- Senaldi, G.;
- Di Perri, G.;
- Di Silverio, A.;
- Minoli, L.
Publication type:
Article
Treating HIV Infection in the Central Nervous System.
Published in:
Drugs, 2017, v. 77, n. 2, p. 145, doi. 10.1007/s40265-016-0678-9
By:
- Calcagno, A.;
- Di Perri, G.;
- Bonora, S.
Publication type:
Article
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase of CD4+ cell count, despite virological failure.
Published in:
2008
By:
- Svicher V;
- Aquaro S;
- D'Arrigo R;
- Artese A;
- Dimonte S;
- Alcaro S;
- Santoro MM;
- Di Perri G;
- Lo Caputo S;
- Bellagamba R;
- Zaccarelli M;
- Visco-Comandini U;
- Antinori A;
- Narciso P;
- Ceccherini-Silberstein F;
- Perno C
Publication type:
Journal Article
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
Published in:
2018
By:
- Guaraldi, G.;
- Malagoli, A.;
- Calcagno, A.;
- Mussi, C.;
- Celesia, B. M.;
- Carli, F.;
- Piconi, S.;
- De Socio, G. V.;
- Cattelan, A. M.;
- Orofino, G.;
- Riva, A.;
- Focà, E.;
- Nozza, S.;
- Di Perri, G.
Publication type:
journal article
Cerebrospinal fluid abacavir concentrations in HIV‐positive patients following once‐daily administration.
Published in:
British Journal of Clinical Pharmacology, 2018, v. 84, n. 6, p. 1380, doi. 10.1111/bcp.13552
By:
- Calcagno, A.;
- Pinnetti, C.;
- De Nicolò, A.;
- Scarvaglieri, E.;
- Gisslen, M.;
- Tempestilli, M.;
- D'Avolio, A.;
- Fedele, V.;
- Di Perri, G.;
- Antinori, A.;
- Bonora, S.
Publication type:
Article
Response to Noe, Oldenbuettel and Jaeger.
Published in:
2020
By:
- Shafran, SD;
- Di Perri, G
Publication type:
Letter to the Editor
Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamide.
Published in:
HIV Medicine, 2019, v. 20, p. 1, doi. 10.1111/hiv.12755
By:
- Shafran, SD;
- Di Perri, G;
- Esser, S;
- Lelièvre, J‐D;
- Parczewski, M
Publication type:
Article
Survival in HIV‐infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study.
Published in:
HIV Medicine, 2018, v. 19, n. 8, p. 523, doi. 10.1111/hiv.12624
By:
- Focà, E.;
- Cavaglià, G.;
- Rusconi, S.;
- Cascavilla, A.;
- Cenderello, G.;
- Re, A.;
- Casari, S.;
- Van Den Bogaart, L.;
- Zinzani, P. L.;
- Caracciolo, D.;
- Di Perri, G.;
- Bonito, A.;
- Lucchini, A.;
- Cassola, G.;
- Viale, P.;
- Calcagno, A.
Publication type:
Article
Diagnostic accuracy of new and old cognitive screening tools for HIV‐associated neurocognitive disorders.
Published in:
HIV Medicine, 2018, v. 19, n. 7, p. 455, doi. 10.1111/hiv.12622
By:
- Trunfio, M.;
- Vai, D.;
- Montrucchio, C.;
- Alcantarini, C.;
- Livelli, A.;
- Tettoni, M. C.;
- Orofino, G.;
- Audagnotto, S.;
- Imperiale, D.;
- Bonora, S.;
- Di Perri, G.;
- Calcagno, A.
Publication type:
Article
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.
Published in:
HIV Medicine, 2016, v. 17, n. 6, p. 471, doi. 10.1111/hiv.12344
By:
- Winston, A;
- Stöhr, W;
- Antinori, A;
- Arenas‐Pinto, A;
- Llibre, JM;
- Amieva, H;
- Cabié, A;
- Williams, I;
- Di Perri, G;
- Tellez, MJ;
- Rockstroh, J;
- Babiker, A;
- Pozniak, A;
- Raffi, F;
- Richert, L;
- Dedes, Nikos;
- Chene, Genevieve;
- Allavena, Clotilde;
- Autran, Brigitte;
- Bucciardini, Raffaella
Publication type:
Article
The role of tenofovir alafenamide in future HIV management.
Published in:
HIV Medicine, 2016, v. 17, p. 4, doi. 10.1111/hiv.12401
By:
- Antela, A.;
- Aguiar, C.;
- Compston, J.;
- Hendry, B. M.;
- Boffito, M.;
- Mallon, P.;
- Pourcher-Martinez, V.;
- Di Perri, G.
Publication type:
Article
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen.
Published in:
Journal of NeuroImmune Pharmacology, 2023, v. 18, n. 4, p. 551, doi. 10.1007/s11481-023-10086-7
By:
- Stroffolini, Giacomo;
- Lazzaro, Alessandro;
- Barco, Ambra;
- Pirriatore, Veronica;
- Vai, Daniela;
- Giaccone, Claudia;
- Nigra, Marco;
- Atzori, Cristiana;
- Trunfio, Mattia;
- Bonora, Stefano;
- Di Perri G, Giovanni;
- Calcagno, Andrea
Publication type:
Article
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.
Published in:
Journal of NeuroImmune Pharmacology, 2017, v. 12, n. 1, p. 187, doi. 10.1007/s11481-016-9717-2
By:
- Calcagno, A.;
- Romito, A.;
- Atzori, C.;
- Ghisetti, V.;
- Cardellino, C.;
- Audagnotto, S.;
- Scarvaglieri, E.;
- Lipani, F.;
- Imperiale, D.;
- Di Perri, G.;
- Bonora, S.
Publication type:
Article
Candida albicans and HIV-1 Infection.
Published in:
Cell Biochemistry & Function, 2000, v. 18, n. 4, p. 235, doi. 10.1002/1099-0844(200012)18:4<235::AID-CBF877>3.0.CO;2-L
By:
- Pugliese, A;
- Torre, D;
- Baccino, F. M;
- Perri, G. Di;
- Cantamessa, C;
- Gerbaudo, L;
- Saini, A;
- Vidotto, V
Publication type:
Article

Found: 67